Inge O. Baas

2.0k citations

42 papers · 1.4k · h-index 15

Impact in

Oncology top 5%
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
Pathology and Forensic Medicine top 5%
- Genetic factors in colorectal cancer

Papers in

Oncology 22
- Cancer survivorship and care 7
- Cancer-related Molecular Pathways 6
- COVID-19 and healthcare impacts 5
- Cancer Treatment and Pharmacology 3
Pulmonary and Respiratory Medicine 9
- Metastasis and carcinoma case studies 3

Co-authors: G. Johan A. Offerhaus (7 shared papers)Stanley R. Hamilton (2 shared papers)Jan‐Willem R. Mulder (2 shared papers)Bert Vogelstein (1 shared paper)Frank M. van den Berg (3 shared papers)William H. Westra (2 shared papers)Robert J.C. Slebos (2 shared papers)G. J. A. Offerhaus (3 shared papers)
Journals: Breast Cancer Research and Treatment (6 papers)Human Pathology (2 papers)The Journal of Pathology (2 papers)Journal of Clinical Pathology (2 papers)International Journal of Cancer (2 papers)
Partner nations: Netherlands United States Switzerland

In The Last Decade

Inge O. Baas

42 papers receiving 1.4k citations

Peers

Countries citing papers authored by Inge O. Baas

Since Specialization

Citations

This map shows the geographic impact of Inge O. Baas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge O. Baas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge O. Baas more than expected).

Fields of papers citing papers by Inge O. Baas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge O. Baas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge O. Baas. The network helps show where Inge O. Baas may publish in the future.

Co-authors

The 25 scholars most cited alongside Inge O. Baas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Inge O. Baas Line = papers co-authored together Inge O. Baas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms The Journal of Pathology ·Inge O. Baas, Jan‐Willem R. Mulder, G. Johan A. Offerhaus, Bert Vogelstein, Stanley R. Hamilton	1994	462
2	K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. PubMed ·William H. Westra, Inge O. Baas, R.H. Hruban, Fredric B Askin, K Wilson, G. J. A. Offerhaus, Robert J.C. Slebos	1996	172
3	Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. PubMed ·Frank M. van den Berg, Inge O. Baas, M Polák, G. Johan A. Offerhaus	1993	92
4	Overexpression of the p53 Tumor Suppressor Gene Product in Primary Lung Adenocarcinomas Is Associated with Cigarette Smoking The American Journal of Surgical Pathology ·William H. Westra, G.J.A. Offerhaus, Steven N. Goodman, Robert J.C. Slebos, Miriam Polak, Inge O. Baas, Sjoerd Rodenhuis, Ralph H. Hruban	1993	79
5	Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors JNCI Cancer Spectrum ·Claudia A. Bargon, Marilot C. T. Batenburg, Lilianne E. van Stam, Dieuwke R. Mink van der Molen, Iris E. van Dam, Femke van der Leij, Inge O. Baas, Miranda F. Ernst, Wiesje Maarse, Nieke Vermulst, Ernst J. P. Schoenmaeckers, Thijs van Dalen, Rhodé M. Bijlsma, Danny A. Young‐Afat, Annemiek Doeksen, Helena M. Verkooijen	2020	55
6	p53 alterations in atypical alveolar hyperplasia of the human lung Human Pathology ·Robbert J.C. Slebos, Inge O. Baas, Marjon J. Clement, G. Johan A. Offerhaus, Fredric B Askin, Ralph H. Hruban, William H. Westra	1998	55
7	c-Myb Regulates the T-Bet-Dependent Differentiation Program in B Cells to Coordinate Antibody Responses Cell Reports ·Dana Piovesan, Jessica C. Tempany, Andrea Di Pietro, Inge O. Baas, Callisthenis Yiannis, Kristy O’Donnell, Yunshun Chen, Victor Peperzak, Gabrielle T. Belz, Charles R. Mackay, Gordon K. Smyth, Joanna R. Groom, David M. Tarlinton, Kim L. Good‐Jacobson	2017	43
8	POTENTIAL FALSE‐POSITIVE RESULTS WITH ANTIGEN ENHANCEMENT FOR IMMUNOHISTOCHEMISTRY OF THE p53 GENE PRODUCT IN COLORECTAL NEOPLASMS The Journal of Pathology ·Inge O. Baas, Frank M. van den Berg, Jan‐Willem R. Mulder, Marjon J. Clement, Robbert J.C. Slebos, Stanley R. Hamilton, G. Johan A. Offerhaus	1996	43
9	Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. Journal of Clinical Pathology ·Inge O. Baas, Bastiaan P. van Rees, Alex R. Musler, M. E. Craanen, G. N. J. Tytgat, Frank M. van den Berg, G. Johan A. Offerhaus	1998	42
10	α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease Biology of Blood and Marrow Transplantation ·Eduardus F. M. Posthuma, Erik W.A. Marijt, Renée M. Y. Barge, Ronald A van Soest, Inge O. Baas, C.W.J. Starrenburg, Shama L. van Zelderen‐Bhola, Willem E. Fibbe, W. M. Smit, Roel Willemze, J.H. Frederik Falkenburg	2004	36
11	Alterations of thep53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area International Journal of Cancer ·Patrick Sturm, Inge O. Baas, Marjon J. Clement, Attila Nakeeb, G. J. A. Offerhaus, Ralph H. Hruban, Henry A. Pitt	1998	30
12	The impact of the COVID-19 pandemic on quality of life, physical and psychosocial wellbeing in breast cancer patients – a prospective, multicenter cohort study European Journal of Cancer ·Claudia A. Bargon, Marilot C. T. Batenburg, L. van Stam, D. Mink van der Molen, Iris van Dam, Feike R. van der Leij, Inge O. Baas, M.F. Ernst, Wiesje Maarse, Nieke Vermulst, Ernst J. P. Schoenmaeckers, Thijs van Dalen, Rhodé M. Bijlsma, Danny A. Young‐Afat, Annemiek Doeksen, Helena M. Verkooijen	2020	23
13	Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells Experimental Hematology ·Marjan Rozenveld-Geugien, Inge O. Baas, Djoke van Gosliga, Edo Vellenga, Jan Jacob Schuringa	2007	21
14	Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands Breast Cancer Research and Treatment ·Carmen van Dooijeweert, Ivette A.G. Deckers, Inge O. Baas, Elsken van der Wall, P. J. van Diest	2019	19
15	Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells Haematologica ·Inge O. Baas, Laura Delvasto-Núñez, Peter C. Ligthart, Conny Brouwer, Claudia C. Folman, Edimara S. Reis, Daniel Ricklin, John D. Lambris, Diana Wouters, Masja de Haas, Ilse Jongerius, Sacha Zeerleder	2019	17
16	First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner European Journal of Nuclear Medicine and Molecular Imaging ·Adrienne H. Brouwers, Joyce van Sluis, Johannes H. van Snick, Carolina P. Schröder, Inge O. Baas, Ronald Boellaard, Andor W.J.M. Glaudemans, Ronald Borra, Adriaan A. Lammertsma, Rudi Dierckx, Charalampos Tsoumpas	2022	14
17	Self-reported work ability in breast cancer survivors; a prospective cohort study in the Netherlands The Breast ·M.L. Gregorowitsch, H.J.G.D. van den Bongard, Couwenberg A.M., Danny A. Young‐Afat, Cees Haaring, Thijs van Dalen, Ernst J. P. Schoenmaeckers, Mariëtte J Agterof, Inge O. Baas, S F, E. Moussa Yagata F., Ragna van Hummel, Helena M. Verkooijen	2019	14
18	Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm Gynecologic and Obstetric Investigation ·Inge O. Baas, Anneke M. Westermann, Benoît You, Pierre-Adrien Bolze, Michael J. Seckl, Ehsan Ghorani	2023	14
19	Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome—A Systematic Review Cancers ·Francis S. P. L. Wens, Caroline C. C. Hulsker, Marta Fiocco, József Zsíros, Stephanie E. Smetsers, Ronald R. de Krijger, Alida F. W. van der Steeg, Ronald P. Zweemer, Inge O. Baas, Eva Maria Roes, Leendert H. J. Looijenga, Cornelis G. Gerestein, Annelies M. C. Mavinkurve‐Groothuis	2023	14
20	The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients Breast Cancer Research and Treatment ·(unknown), M.L. Gregorowitsch, A. Ghedri, Danny A. Young‐Afat, Rhodé M. Bijlsma, Inge O. Baas, Christa van Schaik-van de Mheen, Mariëtte J Agterof, Emine Göker, Daan ten Bokkel Huinink, H.J.G.D. van den Bongard, Helena M. Verkooijen	2019	14

About Inge O. Baas

Inge O. Baas is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Hematology, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Cancer survivorship and care (7 papers), Cancer-related Molecular Pathways (6 papers), Erythrocyte Function and Pathophysiology (5 papers), Blood groups and transfusion (5 papers), COVID-19 and healthcare impacts (5 papers), Cancer Treatment and Pharmacology (3 papers) and Metastasis and carcinoma case studies (3 papers). The work is most often cited by research in Oncology (743 citations), Pathology and Forensic Medicine (325 citations), Cancer Research (231 citations), Pulmonary and Respiratory Medicine (343 citations) and Biotechnology (79 citations). Inge O. Baas has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include G. Johan A. Offerhaus, Stanley R. Hamilton, Jan‐Willem R. Mulder, Bert Vogelstein, Frank M. van den Berg, William H. Westra, Robert J.C. Slebos, G. J. A. Offerhaus, R.H. Hruban and M Polák. Their work appears in journals such as Breast Cancer Research and Treatment, Human Pathology, The Journal of Pathology, Journal of Clinical Pathology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Inge O. Baas

Impact in

Papers in i

In The Last Decade

Inge O. Baas

Peers

Countries citing papers authored by Inge O. Baas

Fields of papers citing papers by Inge O. Baas

All Works

About Inge O. Baas

Explore authors with similar magnitude of impact

Papers in